These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23502781)

  • 21. Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension.
    Li M; Vattulainen S; Aho J; Orcholski M; Rojas V; Yuan K; Helenius M; Taimen P; Myllykangas S; De Jesus Perez V; Koskenvuo JW; Alastalo TP
    Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1118-28. PubMed ID: 24433082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BMPRII influences the response of pulmonary microvascular endothelial cells to inflammatory mediators.
    Vengethasamy L; Hautefort A; Tielemans B; Belge C; Perros F; Verleden S; Fadel E; Van Raemdonck D; Delcroix M; Quarck R
    Pflugers Arch; 2016 Nov; 468(11-12):1969-1983. PubMed ID: 27816994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Copy-number variation in BMPR2 is not associated with the pathogenesis of pulmonary arterial hypertension.
    Johnson JA; Vnencak-Jones CL; Cogan JD; Loyd JE; West J
    BMC Med Genet; 2009 Jun; 10():58. PubMed ID: 19531247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial cell energy metabolism, proliferation, and apoptosis in pulmonary hypertension.
    Xu W; Erzurum SC
    Compr Physiol; 2011 Jan; 1(1):357-72. PubMed ID: 23737177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug.
    Hopper RK; Moonen JR; Diebold I; Cao A; Rhodes CJ; Tojais NF; Hennigs JK; Gu M; Wang L; Rabinovitch M
    Circulation; 2016 May; 133(18):1783-94. PubMed ID: 27045138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension.
    Aldred MA; Comhair SA; Varella-Garcia M; Asosingh K; Xu W; Noon GP; Thistlethwaite PA; Tuder RM; Erzurum SC; Geraci MW; Coldren CD
    Am J Respir Crit Care Med; 2010 Nov; 182(9):1153-60. PubMed ID: 20581168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial-to-mesenchymal transition in pulmonary hypertension.
    Ranchoux B; Antigny F; Rucker-Martin C; Hautefort A; Péchoux C; Bogaard HJ; Dorfmüller P; Remy S; Lecerf F; Planté S; Chat S; Fadel E; Houssaini A; Anegon I; Adnot S; Simonneau G; Humbert M; Cohen-Kaminsky S; Perros F
    Circulation; 2015 Mar; 131(11):1006-18. PubMed ID: 25593290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
    Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells.
    Awad KS; Elinoff JM; Wang S; Gairhe S; Ferreyra GA; Cai R; Sun J; Solomon MA; Danner RL
    Am J Physiol Lung Cell Mol Physiol; 2016 Jan; 310(2):L187-201. PubMed ID: 26589479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells.
    Nickel N; Jonigk D; Kempf T; Bockmeyer CL; Maegel L; Rische J; Laenger F; Lehmann U; Sauer C; Greer M; Welte T; Hoeper MM; Golpon HA
    Respir Res; 2011 May; 12(1):62. PubMed ID: 21548946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered MicroRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8.
    Drake KM; Zygmunt D; Mavrakis L; Harbor P; Wang L; Comhair SA; Erzurum SC; Aldred MA
    Am J Respir Crit Care Med; 2011 Dec; 184(12):1400-8. PubMed ID: 21920918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension.
    Perros F; Montani D; Dorfmüller P; Durand-Gasselin I; Tcherakian C; Le Pavec J; Mazmanian M; Fadel E; Mussot S; Mercier O; Hervé P; Emilie D; Eddahibi S; Simonneau G; Souza R; Humbert M
    Am J Respir Crit Care Med; 2008 Jul; 178(1):81-8. PubMed ID: 18420966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
    Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
    J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of the bone morphogenetic protein system in endothelin- and aldosterone-induced cell proliferation of pulmonary arterial smooth muscle cells isolated from human patients with pulmonary arterial hypertension.
    Yamanaka R; Otsuka F; Nakamura K; Yamashita M; Otani H; Takeda M; Matsumoto Y; Kusano KF; Ito H; Makino H
    Hypertens Res; 2010 May; 33(5):435-45. PubMed ID: 20186146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary veins in the normal lung and pulmonary hypertension due to left heart disease.
    Hunt JM; Bethea B; Liu X; Gandjeva A; Mammen PP; Stacher E; Gandjeva MR; Parish E; Perez M; Smith L; Graham BB; Kuebler WM; Tuder RM
    Am J Physiol Lung Cell Mol Physiol; 2013 Nov; 305(10):L725-36. PubMed ID: 24039255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-HTT, BMPR2, EDN1, ENG, KCNA5 gene polymorphisms and susceptibility to pulmonary arterial hypertension: A meta-analysis.
    Jiao YR; Wang W; Lei PC; Jia HP; Dong J; Gou YQ; Chen CL; Cao J; Wang YF; Zhu YK
    Gene; 2019 Jan; 680():34-42. PubMed ID: 30218748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complex inheritance in Pulmonary Arterial Hypertension patients with several mutations.
    Pousada G; Baloira A; Valverde D
    Sci Rep; 2016 Sep; 6():33570. PubMed ID: 27630060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.
    Sztrymf B; Coulet F; Girerd B; Yaici A; Jais X; Sitbon O; Montani D; Souza R; Simonneau G; Soubrier F; Humbert M
    Am J Respir Crit Care Med; 2008 Jun; 177(12):1377-83. PubMed ID: 18356561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of second genetic hits at the BMPR2 locus as a modulator of disease progression in familial pulmonary arterial hypertension.
    Machado RD; James V; Southwood M; Harrison RE; Atkinson C; Stewart S; Morrell NW; Trembath RC; Aldred MA
    Circulation; 2005 Feb; 111(5):607-13. PubMed ID: 15699281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BMPR2 gene delivery reduces mutation-related PAH and counteracts TGF-β-mediated pulmonary cell signalling.
    Feng F; Harper RL; Reynolds PN
    Respirology; 2016 Apr; 21(3):526-32. PubMed ID: 26689975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.